Northwire Canada EditionSunday, November 8, 2026
Sign inSubscribe
Northwire
⌕
Gold 4,079.60 −0.8% Silver 51.94 −0.8% Copper 6.24 −0.5% Oil 90.83 +0.3% Palladium 1,017.10 −2.6% KRN 0.260 −7.1% GSKR 2.84 +5.6% ADE 0.125 +4.2% NRM 0.055 +0.0% BBB 0.520 −1.9% LGD 2.09 +1.9% DEC 0.110 +0.0% LCE 0.200 +0.0% NILI 0.515 −1.0% CDE 21.85 +6.7% CAN 0.045 +0.0% LORD 0.100 +0.0% HBM 29.49 +2.3% ELEF 0.265 +120.8% MUN 0.300 +0.0% SAGA 0.400 +6.7% Gold 4,079.60 −0.8% Silver 51.94 −0.8% Copper 6.24 −0.5% Oil 90.83 +0.3% Palladium 1,017.10 −2.6% KRN 0.260 −7.1% GSKR 2.84 +5.6% ADE 0.125 +4.2% NRM 0.055 +0.0% BBB 0.520 −1.9% LGD 2.09 +1.9% DEC 0.110 +0.0% LCE 0.200 +0.0% NILI 0.515 −1.0% CDE 21.85 +6.7% CAN 0.045 +0.0% LORD 0.100 +0.0% HBM 29.49 +2.3% ELEF 0.265 +120.8% MUN 0.300 +0.0% SAGA 0.400 +6.7%
Production / Operations

Triera Biosciences Completes Innovative Solutions Canada Contract, Advances Platform Toward New Candidate Development

Triera Advances Flu Platform While Nasdaq Compliance Clock Ticks

By The Northwire Desk — AI Analysis Apr 14, 2026 · 08:31 ZEN · 0.73 Zentek Ltd.
Executive Summary
  • Triera Biosciences (Zentek subsidiary) completed an Innovative Solutions Canada (ISC) contract focused on H5N1 avian influenza aptamer development.
  • Executed Ontario Centres of Innovation (OCI) Collaborate 2 Commercialize agreement for seasonal influenza candidates ($300,000 budget).
  • Shift in focus from pandemic risks to common seasonal Influenza A subtypes (H1N1 and H3N2).
  • Technical scope includes multivalent aptamer engineering, dose-finding, pharmacokinetic modeling, and GLP-style toxicology studies.
  • Previous news confirms Triera launched CRO services for custom aptamer discovery in March 2026 to generate near-term revenue.
Material Impact
  • The news represents incremental progress on the Triera pipeline rather than a fundamental valuation shift.
  • Funding amounts ($300,000 OCI match) are small relative to company operating costs and do not materially extend cash runway compared to October 2025 financing.
  • Operational milestones (GLP studies, seasonal flu focus) validate the technology but do not resolve immediate liquidity or Nasdaq compliance risks.
  • Consistent with historical progression of Triera updates (Sept 2025 H1N1 results, March 2026 CRO launch), indicating expected execution rather than surprise upside.
  • Albany Graphite PEA engagement announced April 9 is a positive catalyst but scheduled for summer completion, limiting immediate price impact.
ZEN · Price
Company Overview
  • Zentek Ltd. operates three core platforms: Albany Graphite Corp., ZenGUARD™ (air filtration), and Triera Biosciences (aptamer diagnostics/therapeutics).
  • Albany Graphite Project: Focus on ultra-high-purity graphite for nuclear, battery, and defense supply chains; confirmed 5N purity (99.9992%) with low boron content suitable for nuclear applications.
  • ZenGUARD™: Enhanced air filtration media targeting infectious aerosol removal; facing regulatory classification challenges in Canada but pursuing US partnerships.
  • Triera Biosciences: Aptamer-based platform licensed from McMaster University; generating revenue via CRO services and government contracts (ISC).
Read the original news release →

More from Zentek Ltd.

Oct 26, 2026 · 06:01

Zentek withdraws from Nasdaq, rejecting share consolidation to preserve capital.

Regulatory Oct 05, 2026 · 07:25

Zentek advances nuclear graphite purification, though a massive capital expenditure gap remains unresolved for the project.

Production / Operations Oct 01, 2026 · 07:41

Zentek’s first federal order validates ZenGUARD filters, though revenue impact remains marginal.

Other Sep 24, 2026 · 07:41

Zentek filed the Albany PEA confirming a $3.85bn NPV and 27.4% IRR for its nuclear-grade graphite project.

Technical Study Sep 16, 2026 · 07:36

Zentek has been pre-qualified for Canadian defence drone coatings, although no committed orders have been secured to date.

Other Sep 14, 2026 · 07:31

Albany Graphite achieves 5N+ purity and secures its first Canadian government orders for the ZenGUARD product line.

Production / Operations